ONVO - PRICE - Organovo Holdings, Inc.

Organovo Holdings, Inc. (ONVO) minimizes risks through a combination of metabolic drug development and services for major laboratories. However, a lack of profitability and a slow pace of innovation are leading to a loss of ground against competitors. The share price illustrated below, which currently stands at , completes the picture of a business creating 3D organ models for testing and future tissue transplantation.

The market value of the share reflects investors' aggregate valuation of future cash flows and capital sensitivity to the company's financial statements. Current price action for Organovo Holdings, Inc. (ONVO) demonstrates the market reaction to business diversification through bioprinting and pharmaceutical testing, which mitigates early-stage risks and determines the fair cash equivalent of a single equity stake in the enterprise.